Skip to main navigation Skip to search Skip to main content

A case of legionellosis during treatment with a TNFα antagonist

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

We report a patient with Legionella pneumophila pneumonia after infliximab therapy for rheumatoid arthritis. Arguments are discussed for an emerging incidence of infections with intracellular microorganisms, granulomatous and non-granulomatous, in patients having received anti-TNFα therapy. These discussions consist of clinical and epidemiological data, experimental data in animals, theoretical evidence, and we provide a possible pathogenetic mechanism.

Original languageEnglish
Pages (from-to)310-311
Number of pages2
JournalScandinavian journal of infectious diseases
Volume36
Issue number4
DOIs
Publication statusPublished - 2004

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A case of legionellosis during treatment with a TNFα antagonist'. Together they form a unique fingerprint.

Cite this